Tag: biomarkers
-
Vanderbilt Team Develops Simple Medical Test Prep Device
Researchers at Vanderbilt University in Nashville are developing a medical collection and preparation system that promises to bring diagnostic testing to the poorest areas of the world. The device, called the Extractionator, is the product of Vanderbilt biomedical engineer Rick Haselton, chemist David Wright, and biochemist Ray Mernaugh. Haselton, Wright, and Mernaugh received a $1…
-
GE, Acorn Research to Partner on Molecular Cancer Testing
Clarient Inc., a division of GE Healthcare in Aliso Viejo, California, and ACORN Research in Memphis have agreed to collaborate on molecular testing of tumor samples to result in standardized molecular profiles that improve the link between testing and treatment. These processes, say the companies, can eventually improve cancer treatment and research by delivering targeted…
-
Gates Foundation, Grand Challenges Canada Fund TB Diagnostic
A device called an Electronic Nose that can detect tuberculosis in the breath of a patient, has received a $950,000 grant from Grand Challenges Canada and the Bill & Melinda Gates Foundation. The funding will support further development and testing of the technology, developed by the International Centre for Genetic Engineering and Biotechnology (ICGEB) in…
-
NIH to Fund Diabetes/Cardiovascular Biomarker Collaboration
Researchers at Arizona State University in Tempe will lead a team funded by National Institutes of Health to discover proteins or biomarkers that help predict cardiovascular disease and to assess new treatments for people with type 2 diabetes. The $5 million, four-year project will include scientists from the Phoenix VA Health Care System, Pfizer Inc.,…
-
Biomarker Test Can Reduce Heart Failure Complications
A clinical trial at Massachusetts General Hospital in Boston indicates that testing for blood levels of a biomarker of cardiac distress, along with standard levels of care, can reduce the incidence of cardiac complications. The findings appear in the 25 October issue of the Journal of the American College of Cardiology (paid subscription required). Roche…
-
Grant Awarded for Study of Blood Test to Spot Concussions
Researchers at the Cleveland Clinic in Ohio have received a grant from National Institutes of Health (NIH) to study the effectiveness of a blood test that identifies concussions in college football players. Damir Janigro and Nicola Marchi of the Cleveland Clinic are the lead researchers on this study, in collaboration with Jeffrey Bazarian at the…
-
U.S., China Universities to Collaborate on Cancer Biomarkers
Arizona State University in Tempe and Sun Yat-Sen University (SYSU) in Guangzhou, China have agreed to collaborate on research developing early and predictive diagnostics for colorectal cancer. The agreement involves the Biodesign Institute’s Center for Sustainable Health at ASU and the SYSU Gastrointestinal Institute of the Sixth Affiliated Hospital in Guangzhou. Research scientists at the…
-
DNA Biomarker Blood Test Aids Prostate Cancer Diagnosis
Researchers at University of Cincinnati and Harvard University have identified a blood test for a DNA biomarker that bolsters the prostate-specific antigen (PSA) test used to screen men for prostate cancer. Their findings appear online in the British Journal of Cancer; paid subscription required. The study led by Cincinnati molecular epidemiologist Tianying Wu (pictured left)…
-
Roche Acquires Cancer Diagnostics Company
The global pharmaceutical company Roche has acquired mtm laboratories AG in Heidelberg, Germany, which specializes in detection and diagnosis of cervical cancer. mtm will become part of Roche’s Ventana Medical Systems Inc. business unit. Under the agreement, Roche will pay mtm shareholders an upfront payment of EUR 130 million (USD 182 million) as well as…
-
New Process Integrates Cancer Lab Studies, Clinical Trials
A joint project of National Cancer Institute (NCI), Jackson Laboratory in Bar Harbor, Maine, and University of California at Davis plans to develop a more consistent model for integrating the results of preclinical cancer research with human clinical trials. The new process comes under NCI’s Advanced Technology Partnerships Initiative and its Center for Advanced Preclinical…